Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 October;61(5) > Minerva Cardioangiologica 2013 October;61(5):499-512

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

  TAVI 2013: WHERE ARE WE NOW? PART II


Minerva Cardioangiologica 2013 October;61(5):499-512

language: English

Role of balloon postdilation following trancatheter aortic valve implantation

Nombela-Franco L., Barbosa Ribeiro H., Allende R., Urena M., Doyle D., Dumont E., Delarochellière R., Rodés-Cabau J.

Quebec Heart and Lung Institute, Quebec City, QC, Canada


PDF  


Paravalvular aortic regurgitation (AR) is a frequent complication following transcatheter aortic valve implantation (TAVI) with an incidence of mild to moderate AR almost systematically higher than 30%. Moreover, several studies have shown that AR has a negative impact on short and mid-term mortality. Balloon postdilation has been proposed as an initial periprocedural option for patients with paravalvular AR to obtain a better expansion of the stent valve frame and potentially reduce the severity of the leak. The aim of this review is to discuss the current available literature on balloon postdilation as a treatment of paravalvular AR after TAVI, its impact on clinical events and future perspectives.

top of page

Publication History

Cite this article as

Corresponding author e-mail

josep.rodes@criucpq.ulaval.ca